HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK2647544

an inhibitor of lipoprotein-associated phospholipase A2; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        Phenyl Ethers: 8
        GSK2647544: 1
- Ethers: 242
  - Phenyl Ethers: 8
    - GSK2647544: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidinones: 71
      - GSK2647544: 1

Experts

1.	Brown, Andrew P: 1 article (01/2017)
2.	Buraglio, Mauro: 1 article (01/2017)
3.	Coello, Christopher: 1 article (01/2017)
4.	Fong, Regan: 1 article (01/2017)
5.	Guan, Chenbing: 1 article (01/2017)
6.	Huiban, Mickael: 1 article (01/2017)
7.	Lewis, Yvonne: 1 article (01/2017)
8.	Lockhart, Andrew: 1 article (01/2017)
9.	Passchier, Jan: 1 article (01/2017)
10.	Rabiner, Eugenii A: 1 article (01/2017)

Related Diseases

1.	Alzheimer Disease (Alzheimer's Disease) 01/01/2017 - "GSK2647544 is a potent and specific inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2), which was in development as a potential treatment for Alzheimer's disease (AD). "

Related Drugs and Biologics

1.	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)